Article Information
History
- December 6, 2021.
Article Versions
- Version 1 (November 1, 2021 - 08:03).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Barbara Adamik1,
- Magdalena Ambrożek-Latecka2,
- Barbara Dragan1,
- Aldona Jeznach3,
- Jakub Śmiechowicz1,
- Waldemar Goździk1 and
- Tomasz Skirecki2,3,*
- 1Department of the Anaesthesiology and Intensive Therapy, Wroclaw Medical University, Wroclaw, Poland
- 2Department of Clinical Cytology, Centre of Postgraduate Medical Education, Warsaw, Poland
- 3Laboratory of Flow Cytometry, Centre of Postgraduate Medical Education, Warsaw, Poland
- ↵*Correspondence: Tomasz Skirecki, Laboratory of Flow Cytometry, Centre of Postgraduate Medical Education, Marymoncka 99/103, 01-813 Warsaw, Poland, Tel +48 22 5693830, Fax +48 22 5693700, Email tskirecki{at}cmkp.edu.pl
Posted December 06, 2021.
Inflammasome-related markers at the ICU admission are not associated with outcome in the critically ill COVID-19 patients
